November 12, 2024. Avelo starts  its pneumonia study, AeroCAP, in collaboration with Prof. Dr. med. Michael Osthoff and his team at...

May 13, 2024. Avelo joins forces with esteemed research partners from the University Hospital Heidelberg (UKHD), Ospedale San Raffaele,...

May 7, 2024. Avelo, a Swiss breath diagnostics company with a mission to make every breath count for better infectious disease diagnosis,...

December 14, 2023. The Swiss breath diagnostics start-up, Avelo, announces that they have received a CHF 1.5M Innosuisse Grant to realize...

October 26, 2023. Avelo, VIVOLTA, and BLINK today announced they have won a €1.5M Eurostars grant to develop a new solution for...

September 7, 2023. Avelo, a Swiss breath diagnostics company with a mission to make every breath count for better infectious disease...

October 6, 2022. Avelo AG, a Swiss breath diagnostics company with a mission to make every breath count for better infectious disease...

The funds will accelerate the clinical validation of the breath collector for non-invasive sampling of patients with Tuberculosis and...

June 30, 2022. Learn more about Avelo and its CEO's entrepreneurial motivation here.

June 29, 2022. Avelo wins CHF 150,000 from VentureKick to make every breath count for better respiratory disease diagnosis. The company...

June 15, 2022. Avelo, in collaboration with the research team at the Zurich University of Applied Sciences (ZHAW) and researchers from...

January 15, 2021. Avelo Inc. welcomes four highly regarded experts in global health, infectious disease diagnostics development,...